IMAX Corporation Q1 2003 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2003. IMAX Corporation designs, manufactures, and leases projector systems for giant screen theaters, produces large-format films, and manufactures high-end sound systems. As of the reporting date, over 230 IMAX theaters were operating in more than 30 countries.
Key Financial Metrics
| Metric | Q1 2003 | Q1 2002 |
|---|---|---|
| Total Revenue | $33.97 million | $31.28 million |
| Gross Margin | $15.71 million (46.2%) | $13.41 million (42.9%) |
| Operating Earnings | $5.94 million | $2.92 million |
| Net Earnings | $2.42 million | $10.55 million |
| Earnings Per Share (Diluted) | $0.07 | $0.32 |
| Cash from Operations | $0.64 million | $5.46 million |
| Cash and Equivalents | $37.11 million | $25.36 million |
| Total Debt (Senior Notes) | $200.00 million | $200.00 million |
| Convertible Subordinated Notes | $9.14 million | $9.14 million |
Note: The Q1 2002 Net Earnings figure includes a one-time gain of $12.2 million from the repurchase of convertible subordinated notes, which was reclassified to continuing operations in the comparative period due to the adoption of FAS 145.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 8.6% year-over-year, driven by 8 theater system installations in Q1 2003 (vs. 6 in Q1 2002) and continued box office success of the film Space Station.
- Profitability: While operating earnings more than doubled to $5.94 million, Net Earnings declined significantly to $2.42 million. This decline is primarily due to the absence of the $12.2 million debt repurchase gain recorded in Q1 2002.
- Expense Management: Selling, general, and administrative (SG&A) expenses decreased by $1.6 million, largely due to lower legal fees following the resolution of several litigation matters in 2002. Research and development expenses increased to $0.71 million to support the new IMAX MPX projection system.
- Cash Flow: Operating cash flow decreased to $0.64 million from $5.46 million, impacted by changes in working capital, including a $9.0 million decrease in deferred revenue.
Outlook, Risks, and Contingencies
- Debt Maturity: The Company repaid the remaining $9.1 million balance of its Convertible Subordinated Notes on April 1, 2003, immediately following the reporting period. Interest expense is expected to decline as a result.
- Strategic Partnership: On April 23, 2003, IMAX announced an agreement with Warner Bros. to distribute IMAX DMR versions of The Matrix Reloaded and The Matrix Revolutions.
- Legal Proceedings: The Company is involved in three primary litigation matters (Big Screen in Germany, Mandalay Resort Group in Nevada, and Muvico Entertainment in Florida). Management believes the allegations are meritless and that potential losses would not materially impact financial position, though no assurance is given.
- Accounting Changes: The Company adopted FAS 145 (reclassifying debt extinguishment gains) and FAS 144 (impairment of long-lived assets) effective January 1, 2003.
- Liquidity: Management believes cash flow from operations and existing cash ($37.1 million) are sufficient to meet operating needs for the next several years.
Investor Verification Checklist
- Verify the impact of the $12.2 million one-time gain in Q1 2002 on year-over-year earnings comparisons.
- Monitor the execution of the Warner Bros. partnership and the release schedule for The Matrix IMAX versions.
- Review the status of outstanding litigation, specifically the Big Screen antitrust defense and the Mandalay Resort Group claim seeking over $4.0 million.
- Assess the realization of the $47.5 million net deferred tax asset, which currently carries a $43.7 million valuation allowance.
- Track the installation rate of new theater systems, as revenue recognition is heavily dependent on installation timing.